Saint Vincent and the Grenadines

Reimbursed Care Access

Saint Vincent and the Grenadines maintains a conventional Caribbean approach: classical psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑X, ibogaine, ayahuasca) are controlled under national drug legislation and have no authorised medical reimbursement outside approved research. Ketamine is used as an essential anaesthetic in health services but psychedelic/off‑label psychiatric uses are not reimbursed; esketamine (Spravato) is not known to be authorised or reimbursed locally. Enforcement for minor possession of cannabis has been relaxed, but this does not extend to the listed psychedelics. [https://www.unodc.org/cld/en/legislation/|UNODC legislative database] [https://legalitylens.com/what-is-the-legality-of-psilocybin-in-saint-vincent-and-the-grenadines/|LegalityLens].